Bodisen Biotech Launches New Product, Expands into
Agricultural Raw Materials Market, Bodisen Sees Strong Customer
Monday February 13, 8:00 am
Bodisen Builds Capacity to Become One of the Largest
Producers of Mancozeb
NEW YORK--(BUSINESS WIRE)--Feb. 13, 2006--Bodisen Biotech, Inc.,
(AMEX:BBC, London AIM:BODI, website: /) the first China based
environmentally friendly bio fertilizer company listed on a US stock
exchange, today announced the launch of its new pesticide raw
materials production line which is expected to make Bodisen one of
the largest producers of Mancozeb in China.
Mancozeb, an essential agricultural raw material for pesticide,
has been in high demand amongst farmers worldwide. Mancozeb is the
most versatile chemical used in the production of fungicides due to
the fact that it can also be utilized as an end product on crops and
not just as a raw material. Bodisen's state of the art facility,
which is expected to be completed in March 2006, will employ some of
the most current agricultural technologies available. The new
manufacturing facility gives Bodisen a competitive advantage, which
it believes will increase its production density up to 20% higher
than its competitors, making Bodisen an emerging leader in China's
agricultural and raw materials markets.
Ms. Karen Qiong Wang, CEO of Bodisen commented, "This is the
beginning of Bodisen's entry into the highly profitable agricultural
raw materials business. It is a natural vertical integration of
Bodisen's existing product lines since we already have some of the
best agricultural product distribution channels that exist in China.
Demand for this new product from our distribution channels
throughout China has been very strong and we see it as one of our
future growth catalysts for our business. The launch of this new
product line will further strengthen Bodisen's leadership position
as one of the fastest growing companies in China."
Ms. Wang continued: "With the completion of our recent financing
in London, Bodisen is in a strategic position to continue to
aggressively grow our business even further into new markets and new
product lines. Our planned two new facilities located in the
northeast and northwest parts of China will each have the same
production capacity and sales growth as our existing facilities.
This is a testament to the strong demand we have and continue to see
and we are excited to be able to execute on our strategic growth
initiatives in meeting this growing demand and generating long term
returns for our growing shareholder base."
In January 2006, Forbes Magazine ranked Bodisen the 16th fastest
growing company in China.
About Bodisen Biotech, Inc.
A Delaware company, Bodisen is headquartered in Shaanxi, China's
agricultural hub. The Bodisen brand is a highly recognized
agricultural product brand in China that is known for fertilizer
products that generate higher yields for farmers. Bodisen's
environmentally friendly "green" products support the mandate of the
Chinese government to increase crop yields for the purpose of
decreasing China's dependency on food imports. Utilizing proprietary
agricultural technologies, Bodisen sells over 60 packaged products,
broken down into 3 product categories: Organic Compound Fertilizer;
Organic Liquid Fertilizer; and Pesticides & Insecticides.
Bodisen's organic fertilizers can be absorbed by plants within 48
hours while enriching soil conditions without the damaging effects
associated with chemical fertilizers. These products address grains,
vegetables, and fruit crops and have been proven to increase crop
yields by 10% to 35% while being 100% environmentally friendly.
Among China's population of 1.3 billion, approximately 900 million
are farmers whose incomes depend on their crop yields. With
approximately 600 (and growing) nationwide distribution centers,
Bodisen has experienced rapid growth in sales in the recent
BODISEN HAS RESEARCH COVERAGE IN NEW YORK AND IN LONDON
Wall Street firm New York Global Securities, Inc. ("NYGS", http://www.newyorkglobal.com/) provides research
coverage for Bodisen. NYGS' parent company New York Global Group (http://www.nyggroup.com/) has a significant China
presence and is one of the largest US firms in China in the
financial services sector. London investment bank Charles Stanley
(http://www.charles-stanley.co.uk/), a member of
the London Stock Exchange since 1852, provides research coverage for
Bodisen in London.
Safe Harbor Statement
This press release may contain forward-looking statements within
the meaning of the "safe harbor" provisions of the Private
Securities Litigation Reform Act of 1995. These statements are based
on the current expectations or beliefs of Bodisen Biotech, Inc.
management and are subject to a number of factors and uncertainties
that could cause actual results to differ materially from those
described in the forward-looking statements.
The Piacente Group, Inc.
Debra Chen, 212-481-1907
Bodisen Biotech, Inc.